EU-funded researchers have developed a carbon with tiny pores that could prevent infection of livers by intestinal bacteria - a common complication in chronic liver disease. The material could improve patients' quality of life and chances of survival, while reducing the use of antibiotics in managing the disease.
The virus that causes chickenpox can also lead to more serious and painful conditions in older people. An EU-funded researcher is discovering how the virus interacts with the immune system and, possibly, how it might be controlled.
EU-funded researchers have developed an efficient colorectal cancer treatment that can prevent relapses in patients post-surgery. It involves applying drugs that kill cancer cells directly to the tumour site, eliminating the need for unpleasant, ongoing injections that can cause side effects.
Many people suffering from curable secondary hypertension - high blood pressure that is the result of a condition - are incorrectly diagnosed, so they don't receive the treatment they need. An EU-funded project's research aims to lead to a blood test that aids diagnosis and improves treatment.
An EU-funded project is carrying out the first clinical trial among elderly cardiac patients of a novel multi-medication pill to prevent recurrent heart attacks, improve the efficacy of care and save lives.
EU-industry funded researchers have worked to identify and characterise signs of cancer, particularly colon cancers, and patients' responses to different types of treatment. The aim is to help doctors choose the best possible treatment for an individual patient's condition, potentially improving and saving lives.
EU and industry-funded researchers have developed a portable device to test in the field whether a person has caught the deadly Ebola disease. It gives reliable results in 75 minutes, which can help contain outbreaks and save lives.
